Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Disclosed deployed
—
across known amounts
Stages
Seed, Series A, Series B, Series C, Growth
About
SBI JI Innovation, established in 2017, is a venture capital firm resulting from a strategic partnership between Japan's SBI Holdings and Israel's Vertex Israel. Initially focused on biopharma, it has expanded its investment scope to include various high-tech sectors. The firm actively seeks and invests in promising Israeli or Israel-related venture-backed companies across different development stages, leveraging the extensive global networks and resources of its parent entities to foster growth and business development.
Portfolio
No portfolio companies in this dataset yet.
Q&A
- What is SBI JI Innovation's primary investment focus?
- SBI JI Innovation focuses on cherry-picking Israeli or Israel-related venture-backed biopharma and high-tech companies across different development stages.
- When was SBI JI Innovation established?
- SBI JI Innovation was established in 2017.
- What is the partnership structure behind SBI JI Innovation?
- SBI JI Innovation is a venture capital firm resulting from a strategic partnership between Japan's SBI Holdings and Israel's Vertex Israel.
- What investment stages does SBI JI Innovation target?
- SBI JI Innovation invests in companies at Seed, Series A, Series B, Series C, and Growth stages.
- Which sectors does SBI JI Innovation prefer for investment?
- SBI JI Innovation prefers sectors such as biopharma, high-tech, biotechnology, healthcare, immunology, immunotherapy, oncology, fintech, cybersecurity, pharmaceuticals, genetic disorders, and insurtech.
- Where is SBI JI Innovation headquartered?
- SBI JI Innovation is headquartered in Tel Aviv-Yafo, Israel.
- Who are some of the key team members at SBI JI Innovation?
- Key team members at SBI JI Innovation include Ryosuke Hayashi as CEO & Managing Director, Masa Tanaka as President, and David Heller as General Partner.